Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Filings indexed 1,643 across all filing types
Latest filing 2006-08-28 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y' and is a 'Change of Director's Interest Notice' under ASX listing rule 3.19A.2. It details a director's personal share transactions, including the number of shares held before and after the transaction, the nature of the transaction (open market trade), and the value involved. There is no financial performance data, management discussion, or report content. This type of document is a report of personal share transactions by company directors and executives, which matches the definition of 'Director's Dealing' (DIRS). The document length is 5540 characters, sufficient to contain detailed transaction information, not just an announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2006-08-28 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y' and references Rule 3.19A.2, which pertains to the 'Change of Director's Interest Notice.' The content details a director's acquisition of shares and options, including dates, number of securities before and after the change, and transaction details. This matches the description of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. There is no indication of financial statements, earnings, or other report types. The document length is 5468 characters, sufficient for a detailed director's dealing notice. Therefore, the document is classified as a Director's Dealing (DIRS).
2006-08-22 English
Financial Results for Quarter & Year Ended June 30 2006 6 pages ?Kb
Earnings Release Classification · 95% confidence The document is a detailed announcement of quarterly and annual financial results for ResMed Inc. for the quarter and year ended June 30, 2006. It includes comprehensive financial data such as revenue, net income, earnings per share, operating expenses, and segment performance. The presence of detailed financial tables and discussion of GAAP and pro forma results indicates this is a full financial report for a fiscal period shorter than a full year (quarterly and annual combined). The document also mentions a conference call to discuss these results, which is typical for earnings releases. The length of the document (15,000 characters) and the detailed financial content confirm it is not merely an announcement or a summary. Therefore, the document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights and financial data.
2006-08-17 English
4th Qtr & Fiscal Year End Earnings Conference Call 1
Call Transcript Classification · 90% confidence The document is an announcement of an upcoming earnings conference call for ResMed's fourth quarter and fiscal year-end results for the period ended June 30, 2006. It provides details about the date and time of the call, how to participate, and replay information. There is no actual financial data or detailed financial report included in the text. The document is essentially a notice about the earnings call event, not the earnings release or transcript itself. Therefore, it fits best into the category of Call Transcript (CT) announcements or earnings call notices. However, since it is only an announcement of the call and not the transcript, the closest fitting category is Call Transcript (CT) as it relates to the earnings call event.
2006-07-19 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director's Interest Notice' and references Appendix 3Y and ASX listing rules related to director's interests. It details the change in securities held by a director, including shares sold and remaining holdings. There is no financial performance data, earnings information, or report publication. The content is focused on personal share transactions by a company director. Therefore, this document fits the category of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement but a detailed notice of director's share transactions.
2006-05-14 English
Record Financial Results for March 31 2006 6 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of quarterly and nine-month financial results for ResMed Inc. It includes comprehensive financial data such as revenue, net income, earnings per share, operating expenses, and segment performance for the quarter and nine months ended March 31, 2006. The presence of detailed financial statements and analysis, including GAAP and pro forma figures, indicates this is a substantive financial report rather than a brief earnings highlight or a simple announcement. The document also mentions a conference call to discuss these results, which is typical for earnings releases. Given the detailed quarterly financial data and the reporting period, this document fits the definition of an Interim / Quarterly Report (IR).
2006-05-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.